These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3286182)

  • 21. Effects on renal function of combined treatment with trimethoprim and cyclosporine A in kidney transplant patients.
    Berg KJ; Nordby G; Rootwelt K; Djøseland O; Fauchald P; Mehl A; Narverud J; Talseth T
    Transplant Proc; 1988 Jun; 20(3):413-5. PubMed ID: 3289171
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cyclosporin in kidney transplantation].
    Land W; Castro LA; Hillebrand G; Klare B; Illner WD; Fornara P
    Internist (Berl); 1985 Sep; 26(9):549-52. PubMed ID: 3905675
    [No Abstract]   [Full Text] [Related]  

  • 23. Impaired fractional excretion of lithium: a very early marker of cyclosporine nephrotoxicity.
    Vincent HH; Wenting GJ; Schalekamp MA; Jeekel J; Weimar W
    Transplant Proc; 1987 Oct; 19(5):4147-8. PubMed ID: 3314004
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevention of chronic cyclosporine nephrotoxicity in renal transplantation by picotamide.
    Quarto Di Palo F; Elli A; Rivolta R; Parenti M; Palazzi P; Zanussi C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):969-71. PubMed ID: 1989347
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical renal transplantation: exfoliative urinary cytology in the evaluation of nephrotoxicity induced by cyclosporin therapy].
    Stella F; Alfani D; Renna Molajoni E; Rossi M; Rossi Lemeni A; Stella C; Di Tondo U; Troccoli R; Cortesini R
    Quad Sclavo Diagn; 1984 Sep; 20(3):295-303. PubMed ID: 6397762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nephrotoxicity of cyclosporin. Clinical, physiopathological and histological aspects].
    Ben Hmida M; Deray G; Brillet G; Faucher C; Beaufils H; Jacobs C
    Ann Med Interne (Paris); 1991; 142(4):288-94. PubMed ID: 1929054
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does nifedipine ameliorate cyclosporin A nephrotoxicity?
    Kwan JT; Foxall PJ; Townend JN; Bending MR; Eisinger AJ
    Br Med J (Clin Res Ed); 1987 Oct; 295(6602):851. PubMed ID: 3119066
    [No Abstract]   [Full Text] [Related]  

  • 29. Urinary cytologic abnormalities in bone marrow transplant recipients of cyclosporin.
    Stella F; Troccoli R; Stella C; Battistelli S; Biagioni S; Giardini C; Baronciani D; Manenti F
    Acta Cytol; 1987; 31(5):615-9. PubMed ID: 3314304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of cyclosporin nephrotoxicity by diuretic therapy.
    Deray G; Baumelou B; Le Hoang P; Aupetit B; Girard B; Baumelou A; Legrand JC; Jacobs C
    Clin Nephrol; 1989 Jul; 32(1):47. PubMed ID: 2758701
    [No Abstract]   [Full Text] [Related]  

  • 31. The case against conversion to azathioprine in cyclosporine-treated renal recipients.
    Flechner SM; Lorber M; Van Buren C; Kerman R; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667
    [No Abstract]   [Full Text] [Related]  

  • 32. Vascular lesions as manifestations of cyclosporin nephrotoxicity.
    Moody H; Matz L; Hurst P
    Lancet; 1986 May; 1(8491):1221-2. PubMed ID: 2871465
    [No Abstract]   [Full Text] [Related]  

  • 33. Nephrotoxicity of trimethoprim and cotrimoxazole in renal allograft recipients treated with cyclosporine.
    Thompson JF; Chalmers DH; Hunnisett AG; Wood RF; Morris PJ
    Transplantation; 1983 Aug; 36(2):204-6. PubMed ID: 6349046
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 35. Potential protective effects of furosemide against early cyclosporine-induced renal injury in hepatic transplant recipients.
    Driscoll DF; Pinson CW; Jenkins RL; Bistrian BR
    Transplant Proc; 1989 Jun; 21(3):3549-50. PubMed ID: 2662523
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclosporine: toxicity, metabolism, and drug interactions--implications from animal studies.
    Whiting PH; Thomson AW; Simpson JG
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):134-44. PubMed ID: 3895654
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacokinetics of cyclosporin A and the significance of blood levels for therapy].
    Wonigeit K
    Internist (Berl); 1985 Sep; 26(9):534-41. PubMed ID: 3905673
    [No Abstract]   [Full Text] [Related]  

  • 38. Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in type I diabetes trials.
    Feutren G
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):356-66. PubMed ID: 3381298
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of chronic renal cyclosporin-A toxicity.
    Klintmalm G
    Nephrologie; 1987; 8(3):131-3. PubMed ID: 3309701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporine-induced nephrotoxicity: pathophysiology of decreased blood flow.
    Curtis JJ; Laskow DA
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):540-3. PubMed ID: 3388498
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.